Pyoderma gangrenosum (PG) is a rare, noninfectious neutro- 
Introduction
Pyoderma gangrenosum is a rare dermatological disease. It is primarily a sterile inflammatory neutrophilic dermatosis. Its etiology is unknown, but it may be an autoimmune disease. It is characterized by recurrent cutaneous ulcerations with mucopurulent or hemorrhagic exudate. These very painful ulcers present with undermined bluish borders and surrounding erythema. Skin lesions are mostly ulcerative with central necrosis. Extracutaneous involvement is reported to occur in bone and lungs (Burns et al., 2004; Wollina, 2007) . Pyoderma gangrenosum may occur in the form of deep ulcers in the oral cavity that sometimes ulcerate through the tonsillar pillar (Greenberg and Glick, 2003) . Pyoderma gangrenosum-like lesions can be seen in patients with ulcerative colitis and crohn's disease (Bork et al., 1993) . Only a few cases of pyoderma gangrenosum with involvement of the oral cavity have, however, been reported (Margoles and Wenger, 1961; Basu and Asquith, 1980; Yusuf and Ead, 1985; Snyder, 1986; Kennedy et al., 1987; Yco et al., 1988; Setterfield et al., 2001; Hiromi, 2008) .
Case Report
A 42-year-old female patient (Figure 1 ) reported to the department of oral medicine and radiology of the Kamineni Institute of Dental Sciences at Narketpally with symptoms of an ulcer on the hard palate and loosening of the upper front teeth for three months. The patient first noticed a papule on the hard palate three months prior, this papule then rupturing, with concomitant exposure of bone. The ulcer thus formed extended anteriorly between teeth 12 and 13.
Figure 1 Extra oral view of patient
On clinical examination: a solitary ulcer was seen on the anterior hard palate, the ulcer being about 4 cm × 2 cm in size, elliptical in shape, with undermined edges. The floor of the ulcer was covered by necrotic bone and pus discharge was noted. The surrounding area of the ulcer was red and inflamed. The ulcer was tender on palpation ( Figure 2 ). There was grade Ⅲ mobility with 13, grade Ⅱ mobility with 12 and 11. Her past medical history revealed that she was suffering from multiple ulcers of the skin on the lower and upper extremities, and on the stomach, for the prior three years. These lesions were recurrent (see Figure 3) . The lesions were diagnosed as pyoderma gangrenosum by a dermatologist. The patient had been receiving corticosteroids, dapsone, cyclosporine, and metrogyl DG gel. capillaries. The histopathological picture was suggestive of a chronic, non-specific suppurative inflammatory lesion. The hard tissue section showed numerous fragments of bone along with necrotic debris. Incisional biopsy from the skin lesion showed thickening and acanthosis of the epidermis with mild spongiosis. There was elongation and uniform broadening of rete ridges with focal blurring of the basement membrane. The papillary dermis showed swelling and necrosis of connective tissue with infiltration of neutrophils and few lymphocytes and eosinophils along with swollen necrosed blood vessels. These features were consistent with pyoderma gangrenosum.
Differential diagnosis included osteo-myelitis of the maxilla, deep fungal infection like histoplasmosis, blastomycosis, mucormycosis, and Wegener's granulomatosis. As the biopsy report was not suggestive of any of other diseases, and pyoderma lesions are expected to show only necrosis and inflammatory reaction, it was finally concluded the patient had an oral mani-festation of pyoderma gangrenosum.
Treatment included extraction of 12, 13 with debridement of the lesion. The patient was also advised to use metronidazole ointment thrice daily over the lesion and to use of chlorhexidine mouth rinse thrice daily, as well as prednisolone 30 mg daily and dapsone. The patient also developed a fresh lesion on the left retromolar area after two weeks, while the lesion on the palate was partially healed. Both of the lesions were completely healed after 6 weeks (Figures 7 and 8) . 
Discussion
Pyoderma gangrenosum is a rare, neutrophilic dermatosis commonly associated with underlying systemic disease. Pyoderma gangre-nosum was first described and named by Brunsting, Goeckerman and O'Leary in 1930 (Burns et al., 2004) . Approximately 50% of patients have an associated systemic disease, commonly inflammatory bowel disease (IBD), ulcerative colitis, arthritis, hematological and lymphoreticular malignancies, or diseases known to be associated with significant immunocompromise, while in another 40%-50% patients, no underlying disease is found. The disease is recurrent in approximately 30% of patients (Setterfield et al., 2001; Burns et al., 2004) . It predominately occurs in adults between the ages of 25-54 years; rarely in children. The classic presentation begins with small tender papules, pustules or nodules which breakdown centrally and rapidly progress to a painful ulcer with characteristic violaceous undermined edges. There may be granulation tissue, necrosis or purulent exudate at the ulcer base. Lesions may be solitary or multiple, commonly found on the lower legs, followed by the thighs, buttocks, chest, head, and neck. Generally, lesions are less than 10 cm in size, but can be very large. Lesions tend to endure, lasting months to years and heal with an atrophic cribri-form scar. Associated symptoms include fever, malaise, myalgia, and arthralgia. Extracutaneous involvement is reported in bone and lungs with neutrophilic infiltrate. The disease may have a variety of clinical presentations: ulcerative, pustular, bullous or atypical, vegetative or superficial granulomatosis (Burns et al., 2004; Wollina, 2007) .
Oral involvement in pyoderma gangrenosum is uncommon. The oral lesions may appear as irregular shaped ulcers 15 mm to 20 mm in diameter with rolled out margins and a grayish colored base. The lesions are painful (Yusuf and Ead, 1985) . Pyostomatitis vegetans is considered to be the oral counterpart of pyoderma gangrenosum (Bork et al., 1993) . This is another rare condition which can occur in association with ulcerative colitis and is characterized by active exacerbations which often coincide with those of the colitis. The lips and cheeks are diffusely swollen with deep fissure-like ulcerations separating papillary projections of the mucous membrane. The patient is often pyrexial with generalized lymphadenopathy (Yusuf and Ead, 1985) .
Previously reported cases of prominent oral mucosal involvement in patients with pyoderma gangrenosum have indicated that the sites of involvement are the tongue, palate, lips, buccal mucosa, gingiva and tonsillar fauces (Margoles and Wenger, 1961; Basu and Asquith, 1980; Yusuf and Ead, 1985; Snyder 1986; Kennedy et al., 1987; Yco et al., 1988; Setterfield et al., 2001; Hiromi, 2008) . In five of the previously reported cases, PG was associated with inflammatory bowel disease, usually ulcerative colitis (UC).
The histopathology of the skin lesions is often variable and nonspecific, but can be useful in excluding other possible etiologies. Findings include: central necrosis and ulceration of the epidermis and dermis surrounded by an intense, acute inflammatory cell infiltrate, with a more peripheral mixed-to-chronic inflammatory cell infiltrate (Burns et al., 2004; Wollina, 2007) . The histopathology of the oral lesions in previously reported cases shows necrosis, ulceration with an overlying fibrinopurulent membrane; heavy infiltration of the lamina propria with chronic inflammatory cells predominately neutrophils and perivascular hyalinization and fibrin deposition (Margoles and Wenger, 1961; Yco et al., 1988; Setterfield et al., 2001) .
As there are no diagnostic features on biopsy, it is of little diagnostic value. The aim of the biopsy is to rule out diagnoses that mimic pyoderma gangrenosum. No specific laboratory test available. Laboratory investigations are done to identify associated diseases and to rule out diagnoses that mimic pyoderma gangrenosum (Burns et al., 2004; Wollina, 2007) . Therefore, the diagnosis is primarily clinical and often a diagnosis of exclusion. Features of the ulcer on clinical examination include tenderness, necrosis, irregular violaceous border, with undermined, rolled edges.
Treatment depends on the disease and the presence of associated diseased. Systemic therapy for early or mild lesions included topical therapy with hydrophilic occlusive dressings, antimicrobial agents or topical or intralesional corticosteroids.
For extensive disease, systemic corticosteroids and cyclosporins are used. For more severe disease, oral corticosteroids, sulphones and other antimicrobial agents like dapsone, clofazimine, minocycline are used. Refractory cases may need pulsed intravenous corticosteroid therapy. Local therapy of the lesions includes pain relief, prevention of secondary bacterial infections and dressings (Burns et al., 2004; Wollina, 2007) . The patient we have described had classical lesions of pyoderma gangrenosum of the legs, wrist and abdomen which were healed. There was no evidence of inflammatory bowel disease in this patient or any of the other described disease associations. The lesion on her palate was consistent with previous reports of a chronic inflammatory lesion with neutrophils. Its occurrence in association with pyoderma gangrenosum elsewhere and its very rapid resolution with systemic steroids suggests that it was also a manifestation of this disease.
